5 Best Oil Service Stocks To Invest In Right Now

Weatherford International (NYSE: WFT  ) is going through an identity crisis of sorts that I'm surprised hasn't raised some legal red flags or caused more concern on Wall Street. The company maintains its main operational office in Houston, was formerly legally based in Bermuda, moved to Switzerland in 2009, and now seeks the greener pastures of Ireland to operate at lower costs and further attract top talent. What's going on here? Is Weatherford gaming the system, or�is it�possibly hiding something? One thing's for sure, this is perfectly legal but something sure doesn't smell right since tax shelters are increasingly being vilified in political circles here in the�United States. Ireland has also been under pressure to make�its tax structures harder to abuse by multinational corporations.�

The oil services player has been looking to capitalize on the favorable tax structure that�the Swiss have benefited for years and years. With greater international scrutiny of Swiss tax laws as well as top executive and board member pay, Weatherford is now hoping to incorporate in Ireland while maintaining its tax domicile in Switzerland. Keep in mind that�tech companies like Apple, Google, and even Facebook�all take advantage of Ireland's favorable tax rate environment. That doesn't make it right for Weatherford to follow�the same�path.�

5 Best Transportation Stocks To Watch For 2015: American Superconductor Corporation(AMSC)

American Superconductor Corporation, together with its subsidiaries, provides wind and power grid products and services primarily in North America, Europe, and the Asia-Pacific. The company?s Wind segment designs, develops, and licenses engineered wind turbine designs to wind turbine manufactures; provides engineering and customer support services; supplies power electronics and software-based control systems to wind turbine manufactures to regulate voltage, control power flows, and maximize wind turbine efficiency; offers consulting services to the wind industry; and provides products that enhance power quality for industrial operations. This segment serves the transmission and distribution, wind power, and manufacturing industries. Its Grid segment manufactures high-temperature superconductor wire and coils; designs and develops superconductor products, such as power cables, fault current limiters, electric motors, generators, and synchronous condensers; manages large-s cale superconductor projects; and provides transmission planning services that identify power grid congestion, poor power quality, and other risks. This segment?s products enable electric utilities and renewable energy project developers to connect, transmit, and distribute power. Its products include D-VAR systems that provide the reactive power needed to stabilize voltage on the grid, and are used to connect wind farms and solar power plants to the power grid; SolarTie Grid Interconnection Systems, which provide the inversion and reactive compensation necessary to connect megawatt-scale solar photovoltaic power plants to the power grid; superconductor wires for various applications, including motors, generators, fault current limiters, and power cables; and power cable systems that are manufactured by third parties, as well as turnkey project management services to electric utilities. American Superconductor Corporation was founded in 1987 and is headquartered in Devens, Massachusetts.

Advisors' Opinion:

• [By Travis Hoium]

  To make matters even more contentious, China has been stealing trade secrets and other intellectual property for years, and that may finally be coming to a head now that it's the second largest economy in the world. Last week, American Superconductor's (NASDAQ: AMSC  ) trade dispute with China was taken to another level when the Department of Justice indicted former AMSC partner Sinovel for stealing trade secrets. All indications are that this should have been an open-and-shut case in China, but the Chinese court system has thrown out the case, or dragged its feet for two years.�

• [By Lisa Levin]

  American Superconductor (NASDAQ: AMSC) shares touched a new 52-week low of $1.89. American Superconductor shares have dropped 39.25% over the past 52 weeks, while the S&P 500 index has gained 26.62% in the same period.

• [By Dan Caplinger]

  On Friday, American Superconductor (NASDAQ: AMSC  ) will release its latest quarterly results. After the loss of its largest customer two years ago, the company has had to make a massive readjustment in its business model, and investors still aren't sure whether it can bounce back from that major setback.

5 Best Oil Service Stocks To Invest In Right Now: ICL Israel Chemicals Ltd (ICL)

ICL Israel Chemicals Ltd (ICL) is an Israel-based company, engaged in the fertilizer and specialty chemical sectors. The company operates in three segments: Fertilizers, Industrial Products, and Performance Products. The Fertilizers segment is engaged in the production of standard, granular, fine red and white potash from three sources, as well as in the production of phosphates, such as phosphate rock, phosphoric acid, fertilizers and animal feed addictives. The Industrial Products segment produces flame retardants, such as brominates and organ phosphorus; elemental bromine, and other chemicals. In addition the Performance Products segment produces specialty phosphates, such as technical, food grade and electronic grade phosphoric acid, phosphate salts, food additives and wildfire safety products, as well as alumina and other chemicals. Advisors' Opinion:

• [By Claudia Maedler]

  In Israel, the TA-25 Index (TA-25) gained 1.9 percent at the close in Tel Aviv as Israel Corp. jumped 9 percent, the most since July 2009, to 1,755 shekels. The shares soared along with those of its Israel Chemicals Ltd. (ICL) unit, which advanced 6.4 percent on speculation that a possible change in ownership of Russian potash producer OAO Uralkali could help stabilize prices of the crop nutrient.

• [By Gwen Ackerman]

  Israel Chemicals Ltd. (ICL), the fourth-largest potash producer in the world by sales, is weighing on the Tel Aviv benchmark stock index on concern the government will exact higher royalties amid a global oversupply.

5 Best Oil Service Stocks To Invest In Right Now: Pinnacle Financial Partners Inc.(PNFP)

Pinnacle Financial Partners, Inc. operates as the bank holding company for Pinnacle National Bank that provides commercial banking products and services to individuals, small-to medium-sized businesses, and professional entities in Tennessee. It offers various deposit products, including savings, checking, interest-bearing checking, money market, and certificate of deposit accounts. The company also offers commercial loans comprising equipment loans and working capital loans; commercial and residential real estate loans, and construction and development loans; and loans to individuals for personal, family, investment, and household purposes, including secured and unsecured installment and term loans, residential first mortgage loans, home equity loans, and home equity lines of credit. In addition, it provides various investment products, such as mutual funds, variable annuities, money market instruments, the United States treasury securities, bonds, fixed annuities, stocks , financial planning, asset management accounts, and listed options; fiduciary and investment management services for individual and commercial clients, including personal trust, endowments, foundations, individual retirement accounts, pensions, and custody services; investment advisory services; and insurance products primarily in the property and casualty area. Further, the company offers telephone and Internet banking, debit cards, automated teller machines, remote and direct deposit, and cash management services. As of January 17, 2012, it operated 29 offices in 8 Middle Tennessee counties and 3 offices in Knoxville. The company was founded in 2000 and is headquartered in Nashville, Tennessee.

Advisors' Opinion:

• [By Brian Pacampara]

  What: Shares of Pinnacle Financial (NASDAQ: PNFP  ) climbed 10% today after the regional bank's quarterly results topped Wall Street expectations.

• [By Monica Gerson]

  Pinnacle Financial Partners (NASDAQ: PNFP) is estimated to post its Q3 earnings at $0.42 per share on revenue of $56.99 million.

  Commerce Bancshares (NASDAQ: CBSH) is projected to report its Q3 earnings at $0.72 per share on revenue of $254.92 million.

5 Best Oil Service Stocks To Invest In Right Now: Prana Biotechnology Ltd (PRAN)

Prana Biotechnology Limited engages in the research and development of therapeutic drugs for the treatment of neurological disorders in Australia. The company primarily focuses on the Alzheimer�s, Parkinson�s, and Huntington�s diseases, as well as various cancer, age-related macular degeneration and cataract, Motor Neuron, and Creutzfeldt-Jakob diseases. Its development stage product line comprises PBT2, a Phase IIb clinical trial product for the treatment of Alzheimer�s disease; and PBT2, a Phase IIa clinical trial product for the treatment of Huntington�s disease. The company was formerly known as Prana Corporation Ltd. and changed its name to Prana Biotechnology Limited in January 2000. Prana Biotechnology Limited was founded in 1997 and is based in Parkville, Australia.

Advisors' Opinion:

• [By Bryan Murphy]

  Considering Eli Lilly & Co. (NYSE:LLY) as well as a co-development project between Johnson & Johnson (NYSE:JNJ) and Pfizer Inc. (NYSE:PFE) both failed in semi-recent effort to develop a similar-functioning Alzheimer's drug, it would be easy to assume that particular route towards an Alzheimer's might be the wrong path to take. Sometimes though, a small tweak or a seemingly-minor nuance with the underlying problem can make all the difference. Enter Prana Biotechnology Limited (NASDAQ:PRAN). Though the company acknowledges its focal point on the development of an Alzheimer's therapy is the same broad premise that ultimately led LLY, PFE, and JNJ to failure, PRAN may have found the proverbial missing link.

• [By Roberto Pedone]

   

   

  Another under-$10 biotechnology player that's starting to trend within range of triggering a major breakout trade is Prana Biotechnology (PRAN), which researches and develops therapeutic drugs for the treatment of neurological disorders in Australia. This stock has been crushed by the bears so far in 2014, with shares off huge by 69%.

   

  If you look at the chart for Prana Biotechnology, you'll notice that this stock recently formed a double bottom chart pattern at $1.90 to $2 a share right above its 50-day moving average of $1.84 a share. Shares of PRAN have been consolidating and moving sideways above its 50-day for the last few weeks. This stock is now starting to spike higher today right above those near-term support levels, and it's quickly pushing within range of triggering a major breakout trade above some key overhead resistance levels.

   

  Market players should now look for long-biased trades in PRAN if it manages to break out above some near-term overhead resistance levels at $2.22 to $2.35 a share and then above some past overhead resistance at $2.47 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 1.98 million shares. If that breakout triggers soon, then PRAN will set up to re-test or possibly take out its gap-down-day high from April at $3.24 a share. Any high-volume move above that level will then give PRAN a chance to re-fill some of its previous gap-down-day zone that started at $10.30 a share.

  Traders can look to buy PRAN off weakness to anticipate that breakout and simply use a stop that sits just below its 50-day moving average of $1.84 a share. One can also buy PRAN off strength once it starts to move above those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

   

• [By James Brumley]

  SGNT stock is also valued at a palatable trailing P/E of 19.8, and has logged six straight quarterly earnings beats, making it one of the best cheap stocks in the pharmaceutical industry.

  Prana Biotechnology (PRAN)

  It’s a slippery slope when you start placing bets based on a company with no marketable product, and a lead candidate that’s only in Phase 2 trials. But, Prana Biotechnology (PRAN) may be one of those cheap stocks within the drugmaking world that’s worth the risk.